Mega Contracts Monitor ($100M+) — August 05, 2026

Leidos secured a $318.4 million BPA call for traveler processing vetting software, with $184.3 million (58%) already outlayed within the first year, indicating rapid deployment and stable revenue through May 2027.

TriWest's $983.9 million firm-fixed-price VA health insurance contract has a performance period of only June 1–30, 2026, creating execution risk and limiting revenue recognition despite the large obligation.

Icahn School of Medicine received a $186.2 million cost-no-fee contract from the CDC, with potential value of $340.8 million over 8 years, providing stable but profitless revenue.

TriWest Healthcare Alliance Corp.'s $983.9 million VA contract has a one-month performance period (June 2026) with zero outlayed funds to date, creating high execution risk if the program is delayed or canceled.

All 4 contracts are civilian, with 2 of 4 (TriWest and Icahn) tied to healthcare agencies (VA and CDC), concentrating exposure to healthcare budget cycles and policy changes.

Leidos' $318.4 million DHS/CBP task order was awarded under full and open competition, leaving it vulnerable to protests or recompetes, though the high outlay rate suggests strong incumbent positioning.

Leidos' $318.4 million DHS/CBP IT task order for traveler vetting software signals sustained civilian IT modernization spending, with potential follow-on contracts as the May 2027 end date approaches.

Icahn School of Medicine's $340.8 million potential value CDC contract (with options) provides a long-term revenue stream for clinical services, though profit is limited by cost-no-fee pricing.

Two of four contracts (TriWest $983.9M and Icahn $186.2M) total $1.17 billion in healthcare obligations, representing 68% of total value, driven by VA and CDC priorities.

Leidos' $318.4 million task order for traveler processing vetting software, with 58% outlayed in the first year, indicates rapid DHS/CBP investment in IT and application development.

{"entity" => "TriWest Healthcare Alliance Corp.", "reason" => "Large $983.9M VA contract with one-month performance period creates execution and revenue recognition risk.", "trigger" => "June 2026 performance start date; outlayed funds tracking"}

{"entity" => "Leidos, Inc.", "reason" => "Strong execution on $318.4M DHS/CBP task order with high outlay rate; watch for follow-on contracts.", "trigger" => "May 2027 end date; option exercises; re-compete announcements"}

{"entity" => "Icahn School of Medicine at Mount Sinai", "reason" => "Long-term $340.8M CDC contract provides stable revenue but cost-no-fee limits profit.", "trigger" => "Option exercises over 8-year period; CDC budget allocations"}